The use of photosensitizing chemicals combined with light in the management of cancer is known as photodynamic therapy. Porphyrin derivatives are the major class of chemicals that have been studied in this regard. Unfortunately, the porphyrin mixture dihematoporphyrin ethers known as Photofrin II suitable for photodynamic therapy possesses several intrinsic disadvantages which led to a search for new photosensitizers with improved therapeutic effects and low phototoxicity. Phthalocyanines have shown some promise in this regard. The purpose of the studies outlined in this proposal is to develop new knowledge regarding the potential usefulness of phthalocyanines in photodynamic therapy of murine skin neoplasms. Virtually no studies have been conducted to define the photodynamic therapy and photosensitization and/or phototoxic effects of phthalocyanines in the skin. In addition we have chosen skin tumors because of extensive experience of this laboratory, because unlike tumor implant systems they develop in their own matrix, because regression of multiple tumors as a function of time can be monitored in the same animal and because same animal can serve as its own control. Tetrasulfonated chloroaluminum phthalocyanine and selected new well defined structures will be synthesized and will be used as the prototype to define their pharmacodynamic and phototoxic effects in normal murine skin and in benign papillomas and squamous cell carcinomas induced by chemical carcinogens in mouse skin in vivo in assay procedures operational in this laboratory. Promising phthalocyanines will be studied to ensure that they possess no or low dark toxicity in the animals. Based on these studies we will select the most promising phthalocyanine for detailed mechanistic studies. The mechanism of phthalocyanine action will be studied in cultured murine keratinocytes and fibroblasts as well as in human keratinocytes and in human epidermoid carcinoma cell line A 431 in vitro to complement and further expand the data obtained from the animal studies. The role of reactive oxygen species in this process including superoxide anion, hydrogen peroxide, hydroxyl radical and singlet oxygen will be explored using quenchers and spin traps combined with electron spin resonance spectroscopy. The role of lipid peroxidation as a mechanism of phthalocyanine action will also be studied. Where appropriate, the photosensitizing effects of phthalocyanines will be compared with those of Photofrin II as a positive control in an effort to determine the superiority of one or another of these classes of photosensitizer for photodynamic therapy. The purpose of these studies is to develop a broader base of knowledge regarding the usefulness of phthalocyanines for the photodynamic therapy of malignant neoplasms in the skin.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA051802-01
Application #
3196472
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1990-04-15
Project End
1995-01-31
Budget Start
1990-04-15
Budget End
1991-01-31
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Subbarayan, Murugesan; Hafeli, Urs O; Feyes, Denise K et al. (2003) A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med 44:650-6
Wang, Steven I; Mukhtar, Hasan (2002) A high-efficiency translational control element with potential for cancer gene therapy. Int J Oncol 20:1269-74
Ahmad, N; Kalka, K; Mukhtar, H (2001) In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy. Oncogene 20:2314-7
Azizuddin, K; Kalka, K; Chiu, S M et al. (2001) Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells. Int J Oncol 18:411-5
Srivastava, M; Ahmad, N; Gupta, S et al. (2001) Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis. J Biol Chem 276:15481-8
Elmets, C A; Singh, D; Tubesing, K et al. (2001) Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 44:425-32
Katiyar, S K; Mukhtar, H (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol 69:719-26
Kalka, K; Merk, H; Mukhtar, H (2000) Photodynamic therapy in dermatology. J Am Acad Dermatol 42:389-413; quiz 414-6
Ahmad, N; Gupta, S; Feyes, D K et al. (2000) Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells. J Invest Dermatol 115:1041-6
Whitacre, C M; Feyes, D K; Satoh, T et al. (2000) Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin Cancer Res 6:2021-7

Showing the most recent 10 out of 42 publications